Sander, Julius
Al-Ghazzawi, Karim
Bechrakis, Nikolaos
Chen, Ying
Neumann, Inga
Eckstein, Anja
Oeverhaus, Michael
Funding for this research was provided by:
Universitätsklinikum Essen
Article History
Received: 18 April 2025
Accepted: 24 August 2025
First Online: 1 October 2025
Declarations
:
: The retrospective study was performed in accordance with the Declaration of Helsinki and approved by the Ethics Commission of the University of Essen (reference number: 22-10729-BO).
: All authors consent to publication.
: The authors declare no competing interests.A. Eckstein, I. Neumann and Y. Chen participate within the clinic in sponsor initiated trials for IGF1R, FCRN and IL6-Blockers. AE has participated also in advisory boards regarding GO treatment.